Tristan Nowak

Tristan Nowak

Auto-generated profile, based on publicly available information

Tristan Nowak

DI R&D CTC, Siemens Healthcare AG, Siemensstrasse 3, Forchheim, Bavaria, 91301, GERMANY

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Radiology
Verified
Journal Article
Closed access
TNTristan Nowak
Tristan Nowak
MEMatthias Eberhard
Matthias Eberhard
BSBernhard Schmidt
Bernhard Schmidt
DFDiana Frey
Diana Frey
ODOliver Distler
Oliver Distler
AEAndré Euler
André Euler
Bone mineral density quantification was accurate and precise using two CT localizer radiographs at energy-integrating detector CT and using a single localizer radiograph obtained with different ene... Background Bone mineral density (BMD) could be derived from CT localizer radiographs and could potentially enable opportunistic osteoporosis screening. Purpose To assess the accuracy and precision ...

1 October 2020 in Atherosclerosis
Verified
Journal Article
Closed access
TSThomas Sartoretti
Thomas Sartoretti
MEMatthias Eberhard
Matthias Eberhard
JRJan Hendrik Rüschoff
Jan Hendrik Rüschoff
HPHubertus Pietsch
Hubertus Pietsch
GJGregor Jost
Gregor Jost
Hatem AlkadhiHatem Alkadhi
Hatem Alkadhi

25 August 2023 in Journal of Cardiovascular Computed Tomography
Verified
Journal Article
Open access
MVMilán Vecsey-Nagy
Milán Vecsey-Nagy
AVA. Varga-Szemes
A. Varga-Szemes
Tilman EmrichTilman Emrich
Tilman Emrich
EZE. Zsarnoczay
E. Zsarnoczay
NNN. Nagy
N. Nagy
BSBalint Szilveszter
Balint Szilveszter
Obtaining accurate coronary artery calcium (CAC) score measurements from CCTA datasets with virtual non-iodine (VNI) algorithms would reduce acquisition time and radiation dose. We aimed to assess the agreement of VNI-derived and conventional true non-contrast (TNC)-based CAC scores and to identify the predictors of accuracy. CCTA datasets were acquired with either 120 or 140 ​kVp. CAC scores and volumes were calculated from TNC and VNI images in 197 consecutive patients undergoing CCTA. CAC density score, mean volume/lesion, aortic Hounsfield units and standard deviations were then measured. Finally, percentage deviation (VNI - TNC/TNC∗100) of CTA-derived CAC scores from non-enhanced scans was calculated for each patient. Predictors (including anthropometric and acquisition parameters, as well as CAC characteristics) of the degree of discrepancy were evaluated using linear regression analysis. While the agreement between TNC and VNI was substantial (mean bias, 6.6; limits of agreement, 178.5/145.3), a non-negligible proportion of patients (36/197, 18.3%) were falsely reclassified as CAC score ​= ​0 on VNI. The use of higher tube voltage significantly decreased the percentage deviation relative to TNC-based values (β ​= ​-0.21 [95%CI: 0.38 to -0.03], p ​= ​0.020) and a higher CAC density score also proved to be an independent predictor of a smaller difference (β ​= ​-0.22 [95%CI: 0.37 to -0.07], p ​= ​0.006). The performance of VNI-based calcium scoring may be improved by increased tube voltage protocols, while the accuracy may be compromised for calcified lesions of lower density. The implementation of VNI in clinical routine, however, needs to be preceded by a solution for detecting smaller lesions as well.

12 November 2024 in Physics in Medicine & Biology
Verified
Journal Article
Closed access
SJSören Jasper
Sören Jasper
JSJoseph Swicklik
Joseph Swicklik
FBFrancis Baffour
Francis Baffour
AFAndrea Ferrero
Andrea Ferrero
ASAhmed O. El Sadaney
Ahmed O. El Sadaney
KRKishore Rajendran
Kishore Rajendran
Objective. To assess the accuracy and stability of areal bone-mineral-density (aBMD) measurements from multi-energy CT localizer radiographs acquired using photon-counting detector (PCD) CT. Approach. A European Spine Phantom (ESP) with hydroxyapatite (HA 0.5, 1.0 and 1.5 g cm−2) was scanned using clinical PCD-CT and a dual-energy x-ray absorptiometry (DXA) to compare aBMD values. To assess aBMD stability and reproducibility, PCD-localizers were acquired twice a day for one week, and once per week for five weeks. Multiple ESP anteroposterior thicknesses (18, 26, 34, and 40 cm) were achieved using a synthetic gel layer and scanned across eight tube current values for both 120 kV (15–120 mA) and 140 kV (10–80 mA). One-way analysis of variance was performed for statistical significance (p < 0.05 considered significant). Quantitative HA and water maps were reconstructed using a prototype material-decomposition software, and aBMD was calculated after background correction. In vivo performance of PCD-based aBMD was illustrated using a patient scan acquired at 140 kV and 40 mA, and lumbar aBMD values were compared with DXA. Main results. The ESP aBMD values from PCD-localizers demonstrated excellent day-to-day stability with a coefficient-of-variation ranging from 0.42% to 0.53%, with mean absolute percentage errors (MAPE) of less than 5% for all three vertebral bodies. The coefficient-of-variation for weekly scans ranged from 0.17% to 0.60%, again with MAPE below 5% for all three vertebral bodies. Across phantom sizes and tube currents, the MAPE values varied ranging from 1.84% to 13.78% for 120 kV, and 1.38%–9.11% for 140 kV. No significant difference was found between different tube currents. For the standard phantom size, DXA showed 11.21% MAPE whereas PCD-CT showed 3.04% MAPE. For the patient scan, deviation between PCD-based aBMD values and those obtained from DXA ranged from 0.07% to 9.82% for different lumbar vertebra. Significance. This study highlights the accuracy and stability of PCD-CT localizers for measuring aBMD. We demonstrated aBMD accuracy across different sizes and showed that higher radiation doses did not inherently increase aBMD accuracy.